Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IPO round-up: K2M lists on Nasdaq; skin Dx firm aims for $25m IPO; Siemens to spin out audiology unit

This article was originally published in Clinica

Executive Summary

Spinal device company K2M has moved ahead with its initial public offering on the Nasdaq, joining the growing wave of medtech floats this year. The Leesburg, Virgina-based firm saw its stock open at $15 per share on 8 May – over 5.4 million shares were traded through the day, dipping to a low of $14.51 and hitting a high of $15.23, before settling back and closing at $15. The pricing is a tad lower than what the company had anticipated. At the end of April, K2M had said in a SEC filing that it planned to sell 8.8 million shares at $16-18 each. K2M, listed under the ticker symbol KTWO, develops complex and minimally invasive technologies to treat difficult and challenging spinal pathologies.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT101564

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel